Moreover, pretreatment with angiotensin receptor blockers (ARBs), ACE inhibitors, or statins may further attenuate VEGF-TKI–induced hypertension and reduce the risk of cardiovascular events, as reported from patient cohort analyses (99, 100). Here, VEGFA is linked to hypertensive disorder.